A Phase 2 Study With IPI-926 in Patients With Myelofibrosis

Clinical trial NCT01371617 · COMPLETED

Trial details

NCT number: NCT01371617
Sponsor: Infinity Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Fibrosis, Bone Marrow

Start date: 2011-10-01
Primary completion: 2012-08-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.